283 related articles for article (PubMed ID: 24925197)
1. Dermatofibrosarcoma protuberans, version 1.2014.
Bichakjian CK; Olencki T; Alam M; Andersen JS; Berg D; Bowen GM; Cheney RT; Daniels GA; Glass LF; Grekin RC; Grossman K; Ho AL; Lewis KD; Lydiatt DD; Morrison WH; Nehal KS; Nelson KC; Nghiem P; Perlis CS; Shaha AR; Thorstad WL; Tuli M; Urist MM; Wang TS; Werchniak AE; Wong SL; Zic JA; McMillian N; Hoffman K; Ho M
J Natl Compr Canc Netw; 2014 Jun; 12(6):863-8. PubMed ID: 24925197
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
4. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
[TBL] [Abstract][Full Text] [Related]
5. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
Kesserwan C; Sokolic R; Cowen EW; Garabedian E; Heselmeyer-Haddad K; Lee CC; Pittaluga S; Ortiz C; Baird K; Lopez-Terrada D; Bridge J; Wayne AS; Candotti F
J Allergy Clin Immunol; 2012 Mar; 129(3):762-769.e1. PubMed ID: 22153773
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
7. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
9. An unusual clinical presentation of myxoid dermatofibrosarcoma protuberans with a prominent vasculature: A potential pitfall in the diagnosis of myxoid soft tissue tumors.
Tran P; Henderson GP; McLemore M
J Cutan Pathol; 2018 Jun; 45(6):419-422. PubMed ID: 29468850
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
11. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
12. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
[TBL] [Abstract][Full Text] [Related]
13. Relapse in dermatofibrosarcoma protuberans: A histological and molecular analysis.
Molina AS; Duprat Neto JP; Bertolli E; da Cunha IW; Fregnani JHTG; Figueiredo PHM; Soares FA; Macedo MP; Pinto Lopes CA; de Abranches Oliveira Santos Filho ID
J Surg Oncol; 2018 Apr; 117(5):845-850. PubMed ID: 29509956
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans: A retrospective study of clinicopathologic features and related Akt/mTOR, STAT3, ERK, cyclin D1, and PD-L1 expression.
Park S; Cho S; Kim M; Park JU; Jeong EC; Choi E; Park JH; Lee C; Chang MS
J Am Acad Dermatol; 2018 Nov; 79(5):843-852. PubMed ID: 29792909
[TBL] [Abstract][Full Text] [Related]
15. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans: a rare entity and review of the literature.
Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K
J BUON; 2014; 19(1):34-41. PubMed ID: 24659640
[TBL] [Abstract][Full Text] [Related]
18. [Dermatofibrosarcoma: Management].
Penel N; El Bedoui S; Robin YM; Decanter G
Bull Cancer; 2018 Nov; 105(11):1094-1101. PubMed ID: 30297237
[TBL] [Abstract][Full Text] [Related]
19. A case of childhood dermatofibrosarcoma protuberans without detected cytogenetic abnormality.
Strauss RM; Merchant WJ; Roberts P; Wright AL; Clark SM
Br J Dermatol; 2003 May; 148(5):1051-5. PubMed ID: 12786842
[TBL] [Abstract][Full Text] [Related]
20. Fibrosarcomatous transformation in dermatofibrosarcoma protuberans of the breast--a case report.
Kim MS; Kim KS; Han HY; Kang YJ; Choi YJ; Kang DW; Kim JH
J Clin Ultrasound; 2009 Sep; 37(7):420-3. PubMed ID: 19536861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]